2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

The clonogenic assay was utilised to ascertain survival PARP inhibitor fraction of cells [36]. Briefly, 350–800 cells have been plated in six-properly flat base ce read more...

2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

PARPi have been employed to induce apoptosis in breast Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensit read more...

2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

HTLV-I-transformed mobile traces (MT-four, MT-two, C8166, C91PL) and ATL-like Suppression of Homologous Recombination by insulin- read more...

2 years ago

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

Human T-cell leukemia virus type I (HTLV-I) is etiologically linked to the development of an aggressive type of peripheral